In the News

Construction underway on first of its kind Center for Brain Health at UT Health Science Center San Antonio

May 2, 2023

The Center for Brain Health will contain 75 exam rooms, 50 faculty offices, a 12-chair non-oncology infusion center and an outpatient pharmacy. The five-level building, 103,500 gross square feet in size, will provide ease of access for families and patients and meet their many needs under one roof. Designed services include advanced clinical and research […]


Science Magazine: Texas Neurologist and Professor elected New American Academy of Neurology President

May 1, 2023

Carlayne Jackson, MD, a specialist in the treatment and research of neuromuscular disorders such as amyotrophic lateral sclerosis (ALS, Lou Gehrig’s disease), neurologist and chair of the Department of Neurology at UT Health San Antonio has been elected as the 38th president of the American Academy of Neurology (AAN). According to the the American Academy […]


Commentary: San Antonio is building a national resource in brain health

April 8, 2023

Originally published by the San Antonio Express-News on April 4, 2023. By William L. Henrich, MD, MACP, and Sudha Seshadri, MD In the coming years, an overwhelming number of people in our community will reach the stage of life when they are at increased risk for Alzheimer’s disease and related dementias. The primary risk factor […]


Texas Public Radio: Petrie Dish podcast: Could Ozempic be used to treat Alzheimer’s disease?

March 27, 2023

Ozempic is a medication to help control blood sugar levels in type two diabetes and, more recently, obesity. Now, it is also being studied for as a potential treatment for Alzheimer’s disease. Listen to Texas Public Radio host, Bonnie Petrie, as she speaks with Sudha Seshadri, MD, founding director of the Biggs Institute for Alzheimer’s […]


San Antonio Report: An Alzheimer’s ‘tsunami’ is coming. In San Antonio, a new brain health center is part of the preparation.

March 13, 2023

The San Antonio Report covers the upcoming Center for Brain Health at UT Health San Antonio that will be first of its kind in San Antonio to address dementia in one place with state of the art research equipment. To read the full article, visit SanAntonioReport.org.



US News: 21 Genes Could Link Midlife Obesity & Alzheimer’s Risk

February 22, 2023

US News and Report features the new research study findings of Claudia Satizabal, PhD, and Sudha Seshadri, MD, of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio. The study reviews the connection between obesity and Alzheimer’s disease-related genes. To read the article, visit USNews.com.



Texas Tribune: The Rio Grande Valley is at the epicenter of an Alzheimer’s spike among Latinos and is now the focus of new research efforts

February 4, 2023

Sudha Seshadri, MD, founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, speaks to the spike of Alzheimer’s disease in South Texas and how in partnership with the University of Texas Rio Grande Valley, the institute is looking at why there are so many cases in South […]



Alzheimer’s disease clinical trial seeks 21 area volunteers

January 30, 2023

Study will evaluate senolytics — drugs that clear defective ‘zombie’ cells A clinical trial conducted at UT Health San Antonio aims to “stomp” out Alzheimer’s disease. Clearing old, damaged “zombie” cells from the brain may be one way to do it. The study, called SToMP-AD (Senolytic Therapy to Modulate the Progression of Alzheimer’s Disease), seeks 21 San […]



UT Health San Antonio specialists to discuss latest treatments of movement disorders

January 26, 2023

Deep brain stimulation, continuous levodopa infusion among topics Four fellowship-trained movement disorders neurologists from UT Health San Antonio will give talks Friday (Jan. 27) at the Parkinson’s Foundation Tri-State Symposium. These physicians will discuss the newest developments in research and clinical trials of Parkinson’s disease and other disorders. The symposium, free and open to the […]


A new era in Alzheimer’s treatment: FDA approval on lecanemab

January 11, 2023

Statement from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio about a timely topic in the news: The U.S. Food and Drug Administration on Friday, Jan. 6, 2023, approved lecanemab, a drug that targets the basic pathophysiology of Alzheimer’s disease. The FDA action is an “accelerated approval” of the […]